Your search for comorbidities returned 82 results

Patients with monitoring device like pacemaker had a significantly increased risk of being diagnosed with AF in comparison to general population with no difference in incidence of AF when 2 different monitoring devices were compared.

The researchers sought to determine whether an interatrial shunt device would improve pulmonary artery function at rest and during exercise in patients without heart failure without lessening systemic blood flow.

The rate of complications and in-hospital mortality was found to be high in patients undergoing transcutaneous lead extraction for implantable device-related infections.

Early mortality after atrial fibrillation ablation may be predicted by the occurrence of heart failure, procedural complications, as well as low hospital AF ablation.

Preferential use of angiotensin-converting enzyme inhibitors over angiotensin receptor blockers should be considered whenever possible, particularly in patients with severe mental health illness.

Researchers sought to determine whether atrial fibrillation increases risk for adverse events in hospitalized patients with ischemic stroke .

Persistent pulmonary hypertension is strong predictor of mortality in older patients who underwent ASD closure.

Researchers evaluated how feasible, safe, and effective evolocumab is at lowering low-density lipoprotein cholesterol when initiated in patients hospitalized with acute coronary syndrome.

Investigators examined the relationship between trends in primary and secondary vascular access sites and vascular access site complications among a cohort of patients who underwent PCI.

Further studies are needed to understand the effect of smoking cessation on outcomes in patients undergoing transcatheter aortic valve replacement.